舒啸尘， 教授、硕士生导师
电邮: | xcshu@suda.edu.cn |
电话: | +86-13862151974 |
地址： | 江苏省苏州市工业园区仁爱路199号 |
邮编： | 215123 |
教育经历
2007.07-2011.10 | 卡罗琳斯卡- 隆德大学医学院(瑞典) | 流行病学 | 医学博士 (流行病学) |
2003.07-2005.05 | 新加坡国立大学 | 流行病与卫生统计学 | 科学硕士 |
1997.09-2000.07 | 中国疾病预防控制中心 | 营养与食品安全 | 医学硕士 |
1992.09-1997.07 | 山东大学 | 预防医学 | 医学本科 |
现任职
2015.05- | 苏州大学公共卫生学院 | 教授（流行病） |
工作经历
2011.11-2015.04 | 瑞典卡罗琳斯卡医学院 | 环境流行病学研究所 | 博士后/研究员 |
2005.06-2007.06 | 新加坡国立癌症中心 | 流行病学与临床研究中心 | 流行病学家 |
2000.08-2002.07 | 中国疾病预防控制中心 | 营养与食品安全所 | 助理研究员 |
主要科研项目
瑞典国家重大专项课题：基于注册大数据的神经和内分泌相关肿瘤的基因-环境风险因素分析
国际癌症组织（IARC）六国合作课题：CEFALO study
国际癌症组织（IARC）十三国合作课题：INTERPHONE study
瑞典-德国政府合作课题：CUP (Cancer of unknown primary) 基因-环境风险因素研究
瑞典-德国政府合作课题：自身免疫性疾病与癌症基因-环境风险因素分析
主要社会活动及学术任职
国家卫生计生委重大新药创制GCP评审专家
科技部科研基金评审专家
ISPOR华西分会委员
中国抗癌协会肿瘤流行病学专业委员会委员(候选)
Karolinska Institutet joint läkare
多家国际著名生物医学类期刊 Editor/Reviewer
获奖情况
2015苏州市独墅湖科教创新区（SEID）高端人才集聚工程(科教杰出人才)
2011年国家自费留学生奖学金
研究兴趣
基于注册大数据癌症基因-环境风险因素分析
基于注册数据的药物上市后远期安全性评估研究
随机化临床试验（RCT）
癌症的筛检及早期诊断
课程教学
负责及参与以医学院为主的本/硕/博教学：循证医学、英文流行病学、现代流行病学、临床流行病学、医学科研方法学等。
代表性研究成果
Giorgio Tettamanti#*, xiaochen shu#, Maral Adel Fahmideh, Joachim Schuz, Martin Röösli, Tore Tynes, Michael A Grotzer, Christoffer Johansen, Lars Klæboe, Claudia E Kuehni,Birgitta Lannering, Lisbeth Samsø Schmidt, Danielle Vienneau and Maria Feychting. Prenatal and postnatal medical conditions and the risk of brain tumors in children and adolescents: an international multicenter case-control study. Cancer Epidemiology, Biomarkers&Prevention. DOI: 10.1158/1055-9965.EPI-16-0451 Published 13 September 2016 (Impact factor: 3.622)
Shu X#*, Prochazka M#, Lannering B, Schüz J, Röösli M, Tynes T, Kuehni CE, Andersen TV, Aydin D, Schmidt LS, Poulsen AH, Klaeboe L, Eggen T, Feychting M. Atopic conditions and brain tumor risk in children and adolescents – an international case-control study (CEFALO). Ann Oncol. 2014 March 7 doi:10.1093. (Impact factor: 11.855)
Shu X*, Ahlbom A, Feychting M. Incidence trends of malignant parotid gland tumors in Swedish and Nordic adults 1970 to 2009. Epidemiology. 2012 Sep;23(5):766-7. (Impact factor: 5.866)
Shu X*, Liu H, Ji J, Sundquist K, Försti A, Sundquist J, Hemminki K. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights? Ann Oncol. 2012 Jan;23(1):269-75. (Impact factor: 11.855)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalised for psoriasis: a population-based cohort study in Sweden. Br J Dermatol. 2011 Jul;165(1):129-36. (Impact factor: 4.351)
Shu X*, Ji J, Sundquist K, Sundquist J, Hemminki K. Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964 to 2006. Ann Oncol. 2011 Jun;22(6):1427-34. (Impact factor: 11.855)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011 Mar;17(3):816-22. (Impact factor: 4.643)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med. 2010 Jul;27(7):791-7. (Impact factor: 3.182)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden. Br J Cancer. 2010 Apr 27;102(9):1397-9. (Impact factor: 4.346)
Hemminki K, Ji J, Sundquist J, Shu X*. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol. 2011 Feb;1;29(4):435-40. (Impact factor: 24.008)
PERSONAL INFORMATION
Shu, Xiaochen, MD, PhD, Professor in Soochow University, China
Email: xcshu@suda.edu.cn
Mobile: +86 13862151974
Visiting/Corresponding address: Renai Rd 199, Suzhou Industry Park (SIP), Suzhou. China, 215123
EDUCATION
2007-2011 | Ph.D. in Epidemiology, Karolinska Institutet-Lund University, Sweden |
2003-2005 | M.Sc. in Epidemiology, National University of Singapore, Singapore |
1997-2000 | M.P.H., Chinese Academy of Preventive Medicine, China |
1992-1997 | M.D., Shandong Medical University, China |
CURRENT POSITION
2015-Now | Professor, School of Public Health, Medical College of Soochow University, China |
PREVIOUS POSITION
2011-2015 | Researcher, Institute of Environmental Medicine, Karolinska Institutet, Sweden |
2005-2007 | Epidemiologist, Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre of Singapore, Singapore |
2002-2003 | Government official, China Food and Drug Administration, China |
2000-2002 | Research associate, Chinese Center for Disease Control and Prevention, China |
FELLOWSHIPS AND AWARDS
2015 | Suzhou Science and Education Innovation Awards for Outstanding Researcher/Lecture, China |
2011 | Chinese Government Awards for Outstanding Students Abroad |
CURRENT RESEARCH INTERESTS
My research has a strong focus on the influence of genetic and environmental factors on chronic diseases, with a main focus on cancer incidence and mortality. I have used data from nationwide registers and national and regional surveys to shed new light on potential genetic and environmental factors associated with the development of various types of cancer. Other research interests include cancer screening and early detection, design and development of RCT, and comparativeness and outcome research.
SELECTED PUBLICATION (*corresponding author,#co-first authorship)
Giorgio Tettamanti#*, xiaochen shu#, Maral Adel Fahmideh, Joachim Schuz, Martin Röösli, Tore Tynes, Michael A Grotzer, Christoffer Johansen, Lars Klæboe, Claudia E Kuehni,Birgitta Lannering, Lisbeth Samsø Schmidt, Danielle Vienneau and Maria Feychting. Prenatal and postnatal medical conditions and the risk of brain tumors in children and adolescents: an international multicenter case-control study. Cancer Epidemiology, Biomarkers&Prevention. DOI: 10.1158/1055-9965.EPI-16-0451 Published 13 September 2016 (Impact factor: 3.622)
Shu X#*, Prochazka M#, Lannering B, Schüz J, Röösli M, Tynes T, Kuehni CE, Andersen TV, Aydin D, Schmidt LS, Poulsen AH, Klaeboe L, Eggen T, Feychting M. Atopic conditions and brain tumor risk in children and adolescents – an international case-control study (CEFALO). Ann Oncol. 2014 March 7 doi:10.1093. (Impact factor: 11.855)
Shu X*, Ahlbom A, Feychting M. Incidence trends of malignant parotid gland tumors in Swedish and Nordic adults 1970 to 2009. Epidemiology. 2012 Sep;23(5):766-7. (Impact factor: 5.866)
Shu X*, Liu H, Ji J, Sundquist K, Försti A, Sundquist J, Hemminki K. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights? Ann Oncol. 2012 Jan;23(1):269-75. (Impact factor: 11.855)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalised for psoriasis: a population-based cohort study in Sweden. Br J Dermatol. 2011 Jul;165(1):129-36. (Impact factor: 4.351)
Shu X*, Ji J, Sundquist K, Sundquist J, Hemminki K. Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964 to 2006. Ann Oncol. 2011 Jun;22(6):1427-34. (Impact factor: 11.855)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011 Mar;17(3):816-22. (Impact factor: 4.643)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med. 2010 Jul;27(7):791-7. (Impact factor: 3.182)
Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden. Br J Cancer. 2010 Apr 27;102(9):1397-9. (Impact factor: 4.346)
Hemminki K, Ji J, Sundquist J, Shu X*. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol. 2011 Feb;1;29(4):435-40. (Impact factor: 24.008)
TEACHING
I am currently in charge of or involved in the teaching of evidence-based medicine, modern epidemiology, epidemiology in English, clinical epidemiology and others for undergraduate, master and doctoral students mainly in Medical College.
LANGUAGE
Chinese: native proficiency
English: full professional proficiency
Swedish: elementary proficiency